The XBP1s contributes to the development of endocrine-resistant breast cancer by upregulating the expression of BCL2, p65/RelA, NCOA3, RRM2, CDC6, and TOP2A [16,20,21,22,23,24]. Here, RELA is linked to breast cancer.